Drug recall · May 6, 2026
Alendronate Sodium Oral Solution recall
Why: This recall is being conducted due to out of specification assay results in a limited number of bottles that were stored on side.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Alendronate Sodium Oral Solution, 70 mg/75 mL, 75 mL, Rx only, 4 x 75 mL Single Dose Bottles, Distr. by: Hikma Pharmaceuticals USA Inc., Berkeley Heights, NJ 07922, NDC 0054-0282-59.
- Lots / codes
Lot # AC2040A, Exp Date: 04/2026
- Quantity
- 4 single dose 75 ml bottles
- Company
- Hikma Pharmaceuticals USA INC, Columbus, OH
- Distribution
- US Nationwide.
- Initiated
- April 7, 2026 · Voluntary: Firm initiated
- Classified
- May 8, 2026
- Reported
- May 6, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Alendronate
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.